Need help finding what you are looking for?
Contact Us
PUBLISHER: Transparency Market Research | PRODUCT CODE: 1420993
PUBLISHER: Transparency Market Research | PRODUCT CODE: 1420993
Thrombin Market (Product: Bovine Thrombin, Human Thrombin, and Recombinant Thrombin; and Dosage Form: Powder Form, Solution Form, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
PUBLISHED:
PAGES: 162 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
Thrombin Market - Scope of Report
TMR's report on the global thrombin market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global thrombin market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global thrombin market from 2023 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the thrombin market.
| Market Snapshot | |
|---|---|
| Market Value in 2023 | US$ 652.2 Mn |
| Market Value in 2031 | US$ 1.1 Bn |
| CAGR | 6.1% |
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global thrombin market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global thrombin market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global thrombin market.
The report delves into the competitive landscape of the global thrombin market. Key players operating in the global thrombin market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global thrombin market profiled in this report.
Key Questions Answered in Global thrombin Market Report:
- What is the sales/revenue generated by thrombin across all regions during the forecast period?
- What are the opportunities in the global thrombin market?
- What are the major drivers, restraints, opportunities, and threats in the market?
- Which regional market is set to expand at the fastest CAGR during the forecast period?
- Which segment is expected to generate the highest revenue globally in 2031?
- Which segment is projected to expand at the highest CAGR during the forecast period?
- What are the market positions of different companies operating in the global market?
Thrombin Market - Research Objectives and Research Approach
The comprehensive report on the global thrombin market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global thrombin market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global thrombin market.
Product Code: TMRGL19580
Table of Contents
1. Preface
- 1.1. Market Definition and Scope
- 1.2. Market Segmentation
- 1.3. Key Research Objectives
- 1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Thrombin Market
4. Market Overview
- 4.1. Introduction
- 4.1.1. Product Definition
- 4.1.2. Industry Evolution / Developments
- 4.2. Overview
- 4.3. Market Dynamics
- 4.3.1. Drivers
- 4.3.2. Restraints
- 4.3.3. Opportunities
- 4.4. Global Thrombin Market Analysis and Forecasts, 2023-2031
5. Key Insights
- 5.1. Current Trends in Thrombin
- 5.2. Technological advancements in Thrombin
- 5.3. COVID-19 Impact Analysis
6. Global Thrombin Market Analysis and Forecasts, by Product
- 6.1. Introduction & Definition
- 6.2. Key Findings / Developments
- 6.3. Market Value Forecast, by Product, 2023-2031
- 6.3.1. Bovine Thrombin
- 6.3.2. Human Thrombin
- 6.3.3. Recombinant Thrombin
- 6.4. Market Attractiveness Analysis, by Product
7. Global Thrombin Market Analysis and Forecasts, by Dosage Form
- 7.1. Introduction & Definition
- 7.2. Key Findings / Developments
- 7.3. Market Value Forecast, by Dosage Form, 2023-2031
- 7.3.1. Powder Form
- 7.3.2. Solution Form
- 7.3.3. Others
- 7.4. Market Attractiveness Analysis, by Dosage Form
8. Global Thrombin Market Analysis and Forecasts, by End-user
- 8.1. Introduction & Definition
- 8.2. Key Findings / Developments
- 8.3. Market Value Forecast, by End-user, 2023-2031
- 8.3.1. Hospitals
- 8.3.2. Diagnostic Centers & Clinics
- 8.3.3. Academic & Research Institutes
- 8.4. Market Attractiveness Analysis, by End-user
9. Global Thrombin Market Analysis and Forecasts, by Region
- 9.1. Key Findings
- 9.2. Market Value Forecast, by Region
- 9.2.1. North America
- 9.2.2. Europe
- 9.2.3. Asia Pacific
- 9.2.4. Latin America
- 9.2.5. Middle East & Africa
- 9.3. Market Attractiveness Analysis, by Region
10. North America Thrombin Market Analysis and Forecast
- 10.1. Introduction
- 10.1.1. Key Findings
- 10.2. Market Value Forecast, by Product, 2023-2031
- 10.2.1. Bovine Thrombin
- 10.2.2. Human Thrombin
- 10.2.3. Recombinant Thrombin
- 10.3. Market Value Forecast, by Dosage Form, 2023-2031
- 10.3.1. Powder Form
- 10.3.2. Solution Form
- 10.3.3. Others
- 10.4. Market Value Forecast, by End-user, 2023-2031
- 10.4.1. Hospitals
- 10.4.2. Diagnostic Centers & Clinics
- 10.4.3. Academic & Research Institutes
- 10.5. Market Value Forecast, by Country, 2023-2031
- 10.5.1. U.S.
- 10.5.2. Canada
- 10.6. Market Attractiveness Analysis
- 10.6.1. By Product
- 10.6.2. By Dosage Form
- 10.6.3. By End-user
- 10.6.4. By Country
11. Europe Thrombin Market Analysis and Forecast
- 11.1. Introduction
- 11.1.1. Key Findings
- 11.2. Market Value Forecast, by Product, 2023-2031
- 11.2.1. Bovine Thrombin
- 11.2.2. Human Thrombin
- 11.2.3. Recombinant Thrombin
- 11.3. Market Value Forecast, by Dosage Form, 2023-2031
- 11.3.1. Powder Form
- 11.3.2. Solution Form
- 11.3.3. Others
- 11.4. Market Value Forecast, by End-user, 2023-2031
- 11.4.1. Hospitals
- 11.4.2. Diagnostic Centers & Clinics
- 11.4.3. Academic & Research Institutes
- 11.5. Market Value Forecast, by Country/Sub-region, 2023-2031
- 11.5.1. Germany
- 11.5.2. U.K.
- 11.5.3. France
- 11.5.4. Italy
- 11.5.5. Spain
- 11.5.6. Rest of Europe
- 11.6. Market Attractiveness Analysis
- 11.6.1. By Product
- 11.6.2. By Dosage Form
- 11.6.3. By End-user
- 11.6.4. By Country/Sub-region
12. Asia Pacific Thrombin Market Analysis and Forecast
- 12.1. Introduction
- 12.1.1. Key Findings
- 12.2. Market Value Forecast, by Product, 2023-2031
- 12.2.1. Bovine Thrombin
- 12.2.2. Human Thrombin
- 12.2.3. Recombinant Thrombin
- 12.3. Market Value Forecast, by Dosage Form, 2023-2031
- 12.3.1. Powder Form
- 12.3.2. Solution Form
- 12.3.3. Others
- 12.4. Market Value Forecast, by End-user, 2023-2031
- 12.4.1. Hospitals
- 12.4.2. Diagnostic Centers & Clinics
- 12.4.3. Academic & Research Institutes
- 12.5. 12.5. Market Value Forecast, by Country/Sub-region, 2023-2031
- 12.5.1. China
- 12.5.2. India
- 12.5.3. Japan
- 12.5.4. Australia & New Zealand
- 12.5.5. Rest of Asia Pacific
- 12.6. Market Attractiveness Analysis
- 12.6.1. By Product
- 12.6.2. By Dosage Form
- 12.6.3. By End-user
- 12.6.4. By Country/Sub-region
13. Latin America Thrombin Market Analysis and Forecast
- 13.1. Introduction
- 13.1.1. Key Findings
- 13.2. Market Value Forecast, by Product, 2023-2031
- 13.2.1. Bovine Thrombin
- 13.2.2. Human Thrombin
- 13.2.3. Recombinant Thrombin
- 13.3. Market Value Forecast, by Dosage Form, 2023-2031
- 13.3.1. Powder Form
- 13.3.2. Solution Form
- 13.3.3. Others
- 13.4. Market Value Forecast, by End-user, 2023-2031
- 13.4.1. Hospitals
- 13.4.2. Diagnostic Centers & Clinics
- 13.4.3. Academic & Research Institutes
- 13.5. Market Value Forecast, by Country/Sub-region, 2023-2031
- 13.5.1. Brazil
- 13.5.2. Mexico
- 13.5.3. Rest of Latin America
- 13.6. Market Attractiveness Analysis
- 13.6.1. By Product
- 13.6.2. By Dosage Form
- 13.6.3. By End-user
- 13.6.4. By Country/Sub-region
14. Middle East & Africa Thrombin Market Analysis and Forecast
- 14.1. Introduction
- 14.1.1. Key Findings
- 14.2. Market Value Forecast, by Product, 2023-2031
- 14.2.1. Bovine Thrombin
- 14.2.2. Human Thrombin
- 14.2.3. Recombinant Thrombin
- 14.3. Market Value Forecast, by Dosage Form, 2023-2031
- 14.3.1. Powder Form
- 14.3.2. Solution Form
- 14.3.3. Others
- 14.4. Market Value Forecast, by End-user, 2023-2031
- 14.4.1. Hospitals
- 14.4.2. Diagnostic Centers & Clinics
- 14.4.3. Academic & Research Institutes
- 14.5. Market Value Forecast, by Country/Sub-region, 2023-2031
- 14.5.1. GCC Countries
- 14.5.2. South Africa
- 14.5.3. Rest of Middle East & Africa
- 14.6. Market Attractiveness Analysis
- 14.6.1. By Product
- 14.6.2. By Dosage Form
- 14.6.3. By End-user
- 14.6.4. By Country/Sub-region
15. Competition Landscape
- 15.1. Market Player - Competition Matrix (By Tier and Size of companies)
- 15.2. Market Share Analysis, by Company (2022)
- 15.3. Company Profiles
- 15.3.1. Johnson & Johnson
- 15.3.1.1. Company Overview
- 15.3.1.2. Financial Overview
- 15.3.1.3. Product Portfolio
- 15.3.1.4. Strategic Overview
- 15.3.1.5. SWOT Analysis
- 15.3.2. Pfizer, Inc.
- 15.3.2.1. Company Overview
- 15.3.2.2. Financial Overview
- 15.3.2.3. Product Portfolio
- 15.3.2.4. Strategic Overview
- 15.3.2.5. SWOT Analysis
- 15.3.3. Mallinckrodt Pharmaceuticals
- 15.3.3.1. Company Overview
- 15.3.3.2. Financial Overview
- 15.3.3.3. Product Portfolio
- 15.3.3.4. Strategic Overview
- 15.3.3.5. SWOT Analysis
- 15.3.4. Shanghai RAAS Blood Products Co., Ltd.
- 15.3.4.1. Company Overview
- 15.3.4.2. Financial Overview
- 15.3.4.3. Product Portfolio
- 15.3.4.4. Strategic Overview
- 15.3.4.5. SWOT Analysis
- 15.3.5. Japan Blood Products Organization
- 15.3.5.1. Company Overview
- 15.3.5.2. Financial Overview
- 15.3.5.3. Product Portfolio
- 15.3.5.4. Strategic Overview
- 15.3.5.5. SWOT Analysis
- 15.3.6. Mochida Pharmaceutical Co., Ltd.
- 15.3.6.1. Company Overview
- 15.3.6.2. Financial Overview
- 15.3.6.3. Product Portfolio
- 15.3.6.4. Strategic Overview
- 15.3.6.5. SWOT Analysis
- 15.3.7. BIOFAC A/S
- 15.3.7.1. Company Overview
- 15.3.7.2. Financial Overview
- 15.3.7.3. Product Portfolio
- 15.3.7.4. Strategic Overview
- 15.3.7.5. SWOT Analysis
- 15.3.8. Biomed-Lublin S.A.
- 15.3.8.1. Company Overview
- 15.3.8.2. Financial Overview
- 15.3.8.3. Product Portfolio
- 15.3.8.4. Strategic Overview
- 15.3.8.5. SWOT Analysis
- 15.3.9. Hualan Biological Engineering, Inc.
- 15.3.9.1. Company Overview
- 15.3.9.2. Financial Overview
- 15.3.9.3. Product Portfolio
- 15.3.9.4. Strategic Overview
- 15.3.9.5. SWOT Analysis
- 15.3.1. Johnson & Johnson
Product Code: TMRGL19580
List of Tables
- Table 01: Global Thrombin Market Value (US$ Mn) Forecast, by Product, 2023-2031
- Table 02: Global Thrombin Market Value (US$ Mn) Forecast, by Dosage Form, 2023-2031
- Table 03: Global Thrombin Market Value (US$ Mn) Forecast, by End-user, 2023-2031
- Table 04: Global Thrombin Market Value (US$ Mn) Forecast, by Region, 2023-2031
- Table 05: North America Thrombin Market Value (US$ Mn) Forecast, by Product, 2023-2031
- Table 06: North America Thrombin Market Value (US$ Mn) Forecast, by Dosage Form, 2023-2031
- Table 07: North America Thrombin Market Value (US$ Mn) Forecast, by End-user, 2023-2031
- Table 08: North America Thrombin Market Value (US$ Mn) Forecast, by Country, 2023-2031
- Table 09: Europe Thrombin Market Value (US$ Mn) Forecast, by Product, 2023-2031
- Table 10: Europe Thrombin Market Value (US$ Mn) Forecast, by Dosage Form, 2023-2031
- Table 11: Europe Thrombin Market Value (US$ Mn) Forecast, by End-user, 2023-2031
- Table 12: Europe Thrombin Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023-2031
- Table 13: Asia Pacific Thrombin Market Value (US$ Mn) Forecast, by Product, 2023-2031
- Table 14: Asia Pacific Thrombin Market Value (US$ Mn) Forecast, by Dosage Form, 2023-2031
- Table 15: Asia Pacific Thrombin Market Value (US$ Mn) Forecast, by End-user, 2023-2031
- Table 16: Asia Pacific Thrombin Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023-2031
- Table 17: Latin America Thrombin Market Value (US$ Mn) Forecast, by Product, 2023-2031
- Table 18: Latin America Thrombin Market Value (US$ Mn) Forecast, by Dosage Form, 2023-2031
- Table 19: Latin America Thrombin Market Value (US$ Mn) Forecast, by End-user, 2023-2031
- Table 20: Latin America Thrombin Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023-2031
- Table 21: Middle East & Africa Thrombin Market Value (US$ Mn) Forecast, by Product, 2023-2031
- Table 22: Middle East & Africa Thrombin Market Value (US$ Mn) Forecast, by Dosage Form, 2023-2031
- Table 23: Middle East & Africa Thrombin Market Value (US$ Mn) Forecast, by End-user, 2023-2031
- Table 24: Middle East & Africa Thrombin Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023-2031
List of Figures
- Figure 01: Global Thrombin Market Value (US$ Mn) Forecast, 2023-2031
- Figure 02: Global Thrombin Market Value Share Analysis, by Product, 2022 and 2031
- Figure 03: Global Thrombin Market Attractiveness Analysis, by Product, 2023-2031
- Figure 04: Global Thrombin Market Value Share Analysis, by Dosage Form 2022 and 2031
- Figure 05: Global Thrombin Market Attractiveness Analysis, by Dosage Form, 2023-2031
- Figure 06: Global Thrombin Market Value Share Analysis, by End-user, 2022 and 2031
- Figure 07: Global Thrombin Market Attractiveness Analysis, by End-user, 2023-2031
- Figure 08: Global Thrombin Market Value Share Analysis, by Region, 2022 and 2031
- Figure 09: Global Thrombin Market Attractiveness Analysis, by Region, 2023-2031
- Figure 10: North America Thrombin Market Value (US$ Mn) Forecast, 2023-2031
- Figure 11: North America Thrombin Market Value Share Analysis, by Product, 2022 and 2031
- Figure 12: North America Thrombin Market Attractiveness Analysis, by Product, 2023-2031
- Figure 13: North America Thrombin Market Value Share Analysis, by Dosage Form, 2022 and 2031
- Figure 14: North America Thrombin Market Attractiveness Analysis, by Dosage Form, 2023-2031
- Figure 15: North America Thrombin Market Value Share Analysis, by End-user, 2022 and 2031
- Figure 16: North America Thrombin Market Attractiveness Analysis, by End-user, 2023-2031
- Figure 17: North America Thrombin Market Value Share Analysis, by Country, 2022 and 2031
- Figure 18: North America Thrombin Market Attractiveness Analysis, by Country, 2023-2031
- Figure 19: Europe Thrombin Market Value (US$ Mn) Forecast, 2023-2031
- Figure 20: Europe Thrombin Market Value Share Analysis, by Product, 2022 and 2031
- Figure 21: Europe Thrombin Market Attractiveness Analysis, by Product, 2023-2031
- Figure 22: Europe Thrombin Market Value Share Analysis, by Dosage Form, 2022 and 2031
- Figure 23: Europe Thrombin Market Attractiveness Analysis, by Dosage Form, 2023-2031
- Figure 24: Europe Thrombin Market Value Share Analysis, by End-user, 2022 and 2031
- Figure 25: Europe Thrombin Market Attractiveness Analysis, by End-user, 2023-2031
- Figure 26: Europe Thrombin Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
- Figure 27: Europe Thrombin Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
- Figure 28: Asia Pacific Thrombin Market Value (US$ Mn) Forecast, 2023-2031
- Figure 29: Asia Pacific Thrombin Market Value Share Analysis, by Product, 2022 and 2031
- Figure 30: Asia Pacific Thrombin Market Attractiveness Analysis, by Product, 2023-2031
- Figure 31: Asia Pacific Thrombin Market Value Share Analysis, by Dosage Form 2022 and 2031
- Figure 32: Asia Pacific Thrombin Market Attractiveness Analysis, by Dosage Form, 2023-2031
- Figure 33: Asia Pacific Thrombin Market Value Share Analysis, by End-user, 2022 and 2031
- Figure 34: Asia Pacific Thrombin Market Attractiveness Analysis, by End-user, 2023-2031
- Figure 35: Asia Pacific Thrombin Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
- Figure 36: Asia Pacific Thrombin Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
- Figure 37: Latin America Thrombin Market Value (US$ Mn) Forecast, 2023-2031
- Figure 38: Latin America Thrombin Market Value Share Analysis, by Product, 2022 and 2031
- Figure 39: Latin America Thrombin Market Attractiveness Analysis, by Product, 2023-2031
- Figure 40: Latin America Thrombin Market Value Share Analysis, by Dosage Form, 2022 and 2031
- Figure 41: Latin America Thrombin Market Attractiveness Analysis, by Dosage Form, 2023-2031
- Figure 42: Latin America Thrombin Market Value Share Analysis, by End-user, 2022 and 2031
- Figure 43: Latin America Thrombin Market Attractiveness Analysis, by End-user, 2023-2031
- Figure 44: Latin America Thrombin Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
- Figure 45: Latin America Thrombin Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
- Figure 46: Middle East & Africa Thrombin Market Value (US$ Mn) Forecast, 2023-2031
- Figure 47: Middle East & Africa Thrombin Market Value Share Analysis, by Product, 2022 and 2031
- Figure 48: Middle East & Africa Thrombin Market Attractiveness Analysis, by Product, 2023-2031
- Figure 49: Middle East & Africa Thrombin Market Value Share Analysis, by Dosage Form, 2022 and 2031
- Figure 50: Middle East & Africa Thrombin Market Attractiveness Analysis, by Dosage Form, 2023-2031
- Figure 51: Middle East & Africa Thrombin Market Value Share Analysis, by End-user, 2022 and 2031
- Figure 52: Middle East & Africa Thrombin Market Attractiveness Analysis, by End-user, 2023-2031
- Figure 53: Middle East & Africa Thrombin Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
- Figure 54: Middle East & Africa Thrombin Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
- Figure 55: Global Thrombin Market Share Analysis, by Company, 2022
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.